July 23, 2014 10:48 PM ET

Pharmaceuticals

Company Overview of HemaQuest Pharmaceuticals, Inc.

Executive Profile

George Stamatoyannopoulos M.D., Dsc

Co-Founder and Director, HemaQuest Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Dr. George Stamatoyannopoulos, Md, Dsc, co-founded HemaQuest Pharmaceuticals, Inc. Dr. Stamatoyannopoulos has served as President of the American Society of Hematology and he is the founding President of the American Society of Gene Therapy. He has founded two other biotechnology companies, Targeted Genetics and Regulome. Dr. Stamatoyannopoulos has more than 400 research publications and is widely acknowledged as a leader of the field of hemoglobinopathies. For over ...

Corporate Headquarters

11995 El Camino Real
San Diego, California 92130

United States

Phone: 858-356-5590
Fax: 858-356-5579

Board Members Memberships

Co-Founder and Director

Education

Doctorate
Ohio University
MD
Ohio University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HemaQuest Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.